Seelos Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of SEEL for the last quarter is 653.00 k USD, and it's 60.84% higher compared to the previous quarter. The net income of Q4 23 is -5.45 M USD.